of 4 /4
HYPERTENSIVE Orbit’s HYPERTENSIVE Portfolio

HYPERTENSIVE - Orbit · 2018. 5. 26. · Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg Olmesartan 40mg + Amlodipine

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: HYPERTENSIVE - Orbit · 2018. 5. 26. · Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg Olmesartan 40mg + Amlodipine

HYPERTENSIVE

Orbit’sHYPERTENSIVE

Portfolio

Page 2: HYPERTENSIVE - Orbit · 2018. 5. 26. · Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg Olmesartan 40mg + Amlodipine

Hypertension (HTN or HT), also known as high blood pressure (HBP), is a long-term medical condition in which the blood pressure in the arteries is persistently elevated.High blood pressure usually does not cause symptoms. Long-term high blood pressure, however, is a major risk factor for coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral vascular disease, vision loss, chronic kidney disease, and dementia.

Below listed the Orbit’s Portfolio

NAME

Ramipril Capsules BP 5 mg

Ramipril Capsules BP 2.5 mg

Ramipril & Hydrochlorothiazide Capsules (2.5 mg + 12.5 mg)

Nifedipine Sustained release tablets 10 mg

Nifedipine Sustained release tablets 20 mg

Enalapril Maleate Tablets USP 10 mg

Enalapril Maleate Tablets USP 5 mg

Amlodipine Besilate Tablets 5 mg

Amlodipine Besilate Tablets 10 mg

Amlodipine and Atenolol Tablets (5 mg + 50 mg)

Nimodipine tablets BP 30 mg

Atenolol Tablet BP 50 mg

Atenolol Tablet BP 100 mg

Propranolol Tablets BP 40 mg

Losartan Potassium Tablets USP 25 mg

Losartan Potassium Tablets USP 50 mg

Losartan Potassium Tablets USP 100 mg

Losartan potassium & Hydrochlorothiazide Tablets USP 50mg + 12.5mg

Lisinopril Tablets BP 5 mg

Lisinopril Tablets BP 10 mg

Atorvastatin Tablets 10 mg

Atorvastatin Tablets 20 mg

Atorvastatin Tablets 40 mg

Isoxsuprine Hydrochloride Sustained Release Tablets 40 mg

HYPERTENSIVE

Page 3: HYPERTENSIVE - Orbit · 2018. 5. 26. · Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg Olmesartan 40mg + Amlodipine

Captopril Tablets BP 25 mg

Captopril Tablets BP 50 mg

Telmisartan Tablets USP 20 mg

Telmisartan Tablets USP 40 mg

Isosorbide Dinitrate Tablets U.S.P. 20 mg

Amlodipine 5/10 mg

Amlodipine 5mg + Atenolol 50mg

Bisoprolol fumrate 2.5mg + Amlodipine 2.5mg

Cilnidipine 5/10mg/20 MG

Cilnidipine 5mg + Chlorthalidone 12.5mg

Clopidogrel Bisulphate 75mg

Clopidogrel Bisulphate 75mg + Aspirine 75mg

Hydrochlorthiazide 12.5/25mg

Irbesartan 150mg + Chlorthalidon 12.5mg

Losartan Pottasium 25/50/100mg

Losartan Pottasium 25/50mg + Ramipril 2.5mg

Metiprolol Succinate 25mg + Telmisartan 40mg

Metoprolol Succinate (Extended Realease) 25/50/100mg

Metoprolol Succinate 25mg + Clopidogrel 75mg

Nebivilol 5mg + S-Amlodipine 2.5mg

Nebivolol Hcl 5/10mg

Nicorandil 5/10mg

Olmesaratan Medoximil 20mg + Amlodipine Basilate 5mg

Olmesartan Medoxomil 20/40mg + chlorthalidone 12.5mg

Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg

Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg

Olmesartan 40mg + Amlodipine 5mg

Propanolol Hcl 10mg

Ramipril 2.5/5/10mg

Telmisartan 20/40/80 mg

Telmisartan40mg + Amlodipine 5mg

Telmisartan 40mg + Chlorthalidone 12.5mg

Telmisartan 40mg + Cilnidipine 10mg

Page 4: HYPERTENSIVE - Orbit · 2018. 5. 26. · Olmesartan Medoxomil 20/40mg + Hydrochlorthiazide 12.5mg Olmesartan 20mg + Amlodipine 5mg + Hydrochlorthiazide 12.5 mg Olmesartan 40mg + Amlodipine

ABOUT ORBIT

Orbit LifeSciences - Pioneer In Delivering Health Outcomes

The information in this document is the property of Orbit or its licensors and is protected by copyright and other intellectual property laws. The information in this document is confidential and may be legally privileged or exempt from disclosure under applicable law and shall not attach any liability on the originator. It is intended solely for the addressee. This document shall and will neither be copied, distributed nor have the contents disseminated to anyone else aside from the addressee, without the prior approval of Alhev Access to this document by anyone else is unauthorized. If you are not the intended recipient, or a person responsible for delivery of this document to an intended recipient, any disclosure, copying, distribution or any action taken or omitted to be taken in reliance on it, is prohibited and may be unlawful. Also, you may not copy, print, store, deliver, disseminate or distribute this document to anyone. If you have received this document in error or in such a case, as described herein, please destroy this document and any copies immediately and notify the sender by email at [email protected]

When addressed to our clients, any opinions or advice contained in this document are subject to the terms and conditions expressed in the governing Orbit - client engagement letter. While the Orbit team tries its best to keep the information up-to-date in line with the evolving trends, Orbit assumes no responsibility for the validity and correctness of the information provided.

Orbit Lifesciences is on a mission to deliver quality health through its innovative, evolving and growing product portfolio. Launched in 2004, Orbit is a part of Orbit Group.

With a strong focus on innovation, speed of execution & extensive networking Today, orbit Lifescience is reckoned as one of the fastest growing, multi-faceted progressive professional organization in building and delivering mutually beneficial business propositions ranging from In-licensing, Out-licensing and Exports of Finished Formulations.

This is Orbit Proprietary Material.